Masimo (NASDAQ:MASI) Releases FY25 Earnings Guidance

Masimo (NASDAQ:MASI - Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided EPS guidance of $4.90-$5.10 for the period, compared to the consensus EPS estimate of $4.74. Masimo also updated its FY 2024 guidance to 4.100-4.100 EPS.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on MASI. Piper Sandler lifted their price objective on shares of Masimo from $180.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, December 18th. Wells Fargo & Company lifted their price objective on shares of Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a research note on Wednesday, December 11th. Stifel Nicolaus reissued a "buy" rating and issued a $190.00 price objective (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research note on Thursday. Finally, Raymond James lifted their price objective on shares of Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a research note on Friday, December 27th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $179.67.

Masimo Price Performance

Shares of NASDAQ MASI traded down $2.13 during midday trading on Thursday, reaching $169.94. 992,781 shares of the company were exchanged, compared to its average volume of 535,351. The stock's 50-day moving average price is $168.86 and its 200-day moving average price is $139.54. The stock has a market cap of $9.10 billion, a P/E ratio of 117.20 and a beta of 1.01. Masimo has a one year low of $101.61 and a one year high of $180.97. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, topping analysts' consensus estimates of $0.84 by $0.14. The company had revenue of $504.60 million for the quarter, compared to analyst estimates of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. Masimo's revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.63 earnings per share. On average, sell-side analysts anticipate that Masimo will post 4.03 earnings per share for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.